Skip to main content
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1977 Aug;70(8):525–529. doi: 10.1177/003591577707000804

Genetically determined immune hyperreactivity in human liver disease.

A L Eddleston
PMCID: PMC1543300  PMID: 411134

Full text

PDF
525

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Denman A. M., Barnes R. D. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971 Jul 17;2(7716):135–140. doi: 10.1016/s0140-6736(71)92306-3. [DOI] [PubMed] [Google Scholar]
  2. Bach J. F., Zingraff J., Descamps B., Naret C., Jungers P. Letter: HL-A 1,8 phenotype and HBs antigenaemia in haemodialysis patients. Lancet. 1975 Oct 11;2(7937):707–707. doi: 10.1016/s0140-6736(75)90803-x. [DOI] [PubMed] [Google Scholar]
  3. Cochrane A. M., Moussouros A., Thomsom A. D., Eddleston A. L., Wiiliams R. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet. 1976 Feb 28;1(7957):441–444. doi: 10.1016/s0140-6736(76)91472-0. [DOI] [PubMed] [Google Scholar]
  4. Cudworth A. G., Woodrow J. C. HL-A system and diabetes mellitus. Diabetes. 1975 Apr;24(4):345–349. doi: 10.2337/diab.24.4.345. [DOI] [PubMed] [Google Scholar]
  5. Da Costa J. A., White A. G., Parker A. C., Grigor G. B. Increased incidence of HL-A 1 and 8 in patients showing IgG or complement coating on their red cells. J Clin Pathol. 1974 May;27(5):353–355. doi: 10.1136/jcp.27.5.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eddleston A. L., Williams R. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974 Dec 28;2(7896):1543–1545. doi: 10.1016/s0140-6736(74)90287-6. [DOI] [PubMed] [Google Scholar]
  7. Galbraith R. M., Eddleston A. L., Williams R., Webster A. D., Pattison J., Doniach D., Kennedy L. A., Batchelor J. R. Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet. 1976 May 1;1(7966):930–934. doi: 10.1016/s0140-6736(76)92712-4. [DOI] [PubMed] [Google Scholar]
  8. Galbraith R. M., Smith M., Mackenzie R. M., Tee D. E., Doniach D., Williams R. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. N Engl J Med. 1974 Jan 10;290(2):63–69. doi: 10.1056/NEJM197401102900201. [DOI] [PubMed] [Google Scholar]
  9. Gebhard R. L., Katz S. I., Marks J., Shuster S., Trapani R. J. HL-A antigen type and small-intestinal disease in dermatitis herpetiformis. Lancet. 1973 Oct 6;2(7832):760–762. doi: 10.1016/s0140-6736(73)91039-8. [DOI] [PubMed] [Google Scholar]
  10. Mackay I. R., Morris P. J. Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet. 1972 Oct 14;2(7781):793–795. doi: 10.1016/s0140-6736(72)92149-6. [DOI] [PubMed] [Google Scholar]
  11. Mickey M. R., Kreisler M., Albert E. D., Tanaka N., Terasaki P. I. Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens. 1971;1(2):57–67. doi: 10.1111/j.1399-0039.1971.tb00079.x. [DOI] [PubMed] [Google Scholar]
  12. Morris P. J., Irvine W. J., Gray R. S., Duncan L. J., Vaughan H., McCallum F. J., Campbell C. J., Farquhar J. W. HLA and pancreatic islet cell antibodies in diabetes. Lancet. 1976 Sep 25;2(7987):652–653. doi: 10.1016/s0140-6736(76)92464-8. [DOI] [PubMed] [Google Scholar]
  13. Pirskanen R., Tiilikainen A., Hokkanen E. Histocompatibility (HL-A) antigens associated with myasthenia gravis. A preliminary report. Ann Clin Res. 1972 Oct;4(5):304–306. [PubMed] [Google Scholar]
  14. Platz P., Ryder L., Nielsen L. S., Svejgaard A., Thomsen M., Nerup J., Christy M. Letter: HL-A and idiopathic Addison's disease. Lancet. 1974 Aug 3;2(7875):289–289. doi: 10.1016/s0140-6736(74)91450-0. [DOI] [PubMed] [Google Scholar]
  15. Richman D. P., Patrick J., Arnason B. G. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. N Engl J Med. 1976 Mar 25;294(13):694–698. doi: 10.1056/NEJM197603252941304. [DOI] [PubMed] [Google Scholar]
  16. Stokes P. L., Asquith P., Holmes G. K., Mackintosh P., Cooke W. T. Histocompatibility antigens associated with adult coeliac disease. Lancet. 1972 Jul 22;2(7769):162–164. doi: 10.1016/s0140-6736(72)91330-x. [DOI] [PubMed] [Google Scholar]
  17. Triger D. R., MacCallum F. O., Kurtz J. B., Wright R. Raised antibody titres to measles and rubella viruses in chronic active hepatitis. Lancet. 1972 Mar 25;1(7752):665–667. doi: 10.1016/s0140-6736(72)90465-5. [DOI] [PubMed] [Google Scholar]
  18. Turner M. W., Brostoff T. J., Wells R. S., Stokes C. R., Soothill J. F. HLA in eczema and hay fever. Clin Exp Immunol. 1977 Jan;27(1):43–47. [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES